Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal-specific septin-3 (SEPTIN3) is a member of the septin family of filament-forming GTP-binding proteins[3][2][1]. SEPTIN3 is highly expressed in neurons, especially in brain tissue, and is thought to play roles in synaptic vesicle recycling and maintenance of membrane compartmentalization, possibly by forming diffusion barriers and scaffolds for protein assembly at intracellular sites[1]. Structurally, SEPTIN3 can assemble into filaments and heterooligomeric complexes—most notably with SEPT5 and SEPT7 in rat brain[1]. It contains a GTP-binding domain (G-domain), is capable of nucleotide binding, and forms unique interfaces critical for filament assembly[2][4]. SEPTIN3-group members distinguish themselves by lack of a C-terminal coiled-coil domain, a structural element present in other septins[4]. The biological function of SEPTIN3 is not fully elucidated, and while septins as a group are linked to diverse cellular mechanics, SEPTIN3 itself is not associated with direct drug targeting, disease mutation, or clinical biomarker status[3][1].
Not applicable (no approved drugs or well-characterized experimental modulators for SEPTIN3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal-specific septin-3 (SEPT3).